Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
BMC Cancer|February 5, 2025
Benchmarking LLM chatbots' oncological knowledge with the Turkish Society of Medical Oncology's annual board examination questionsEfe Cem Erdat, Engin Eren KavakBMC Medical Ethics|July 4, 2025
Turkish medical oncologists' perspectives on integrating artificial intelligence: knowledge, attitudes, and ethical considerationsEfe Cem Erdat, Filiz Çay ŞenlerFuture Oncology (London, England)|April 22, 2024
Accuracy and usability of artificial intelligence chatbot generated chemotherapy protocolsEfe Cem Erdat, Merih Yalciner, Yuksel UrunJournal of Gastrointestinal Cancer|November 18, 2022
Enhancing the Anti-angiogenic Effect of Bevacizumab with ACE Inhibition on mCRCEfe Cem Erdat, Elif Berna Koksoy, Gungor UtkanIn Vivo (Athens, Greece)|June 27, 2025
The Effect of Metformin Usage in Patients With Metastatic Colorectal Cancer Receiving First-line Systemic TherapyEfe Cem Erdat, Merih Yalciner, Yasemin Geris, et al.In Vivo (Athens, Greece)|October 30, 2024
The Effect of Statin Usage on Survival in Metastatic Colorectal Cancer Patients Receiving RegorafenibEfe Cem Erdat, Engin Eren Kavak, Merih Yalciner, et al.BMC Geriatrics|December 13, 2025
Challenging the age barrier: comparative outcomes in octogenarian and non-octogenarian colorectal cancer patientsEngin Eren Kavak, İsmail Dilli, Efe Cem Erdat, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 26, 2025
Assessing the accuracy of the GPT-4 model in multidisciplinary tumor board decision predictionEfe Cem Erdat, Merih Yalçıner, Mehmet Berk Örüncü, et al.Journal of Clinical Medicine|April 14, 2026
CEA and CA-19-9 Dynamics Associate with Survival in Regorafenib-Treated Metastatic Colorectal Cancer: A Real-World AnalysisMerih Yalçıner, Mehmet Berk Örüncü, Mehmet Kayaalp, et al.Cancer Diagnosis & Prognosis|July 2, 2025
Predictive Value of Incidental Cross-Sectional Imaging for Prediction of Skeletal Events in Patients With Prostate CancerMerih Yalçiner, Efe Cem Erdat, Sati Coşkun Yazgan, et al.Pageof 2